[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.201.14. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1982

Sjögren's Syndrome and Polymyositis or Dermatomyositis

Author Affiliations

From the Department of Neurology (Dr Ringel and Ms Wehling) and the Division of Rheumatology, Department of Internal Medicine (Drs Forstot, Tan, and Butcher), University of Colorado Health Sciences Center, Denver; and the Department of Neurology (Dr Griggs), University of Rochester, NY.

Arch Neurol. 1982;39(3):157-163. doi:10.1001/archneur.1982.00510150027007
Abstract

• Of four patients with Sjögren's syndrome, three had polymyositis and one had dermatomyositis. In all, deposition of IgG, IgA, IgM, and C3 was observed in muscle by immunofluorescent techniques. Serologic studies revealed elevated levels of serum IgG and IgM, rheumatoid factor, and antinuclear antibody with specificity for SS-A and SS-B antigens. In muscle there was a mononuclear cell infiltrate with plasma cell predominance around small vessels and capillaries. Ultrastructural changes in the vessels included reduplication of the basement membrane, endothelial thickening, and numerous tubuloreticular and dense inclusions. In two patients, electrondense deposits were noted in the microvasculature. This combination of immunoglobulin deposition in muscle, prominent microvascular changes, and characteristic serology suggests that the myositis in Sjögren's syndrome may result from small-vessel injury by autoantibodies or circulating immune complexes.

×